Skip to main content
Clinical Trials/EUCTR2011-000739-97-AT
EUCTR2011-000739-97-ATActive, not recruitingPhase 1

Prospective, randomized, controlled, open-label study evaluating quality of life in patients with advanced malignant tumors with and without add-on” homeopathy - HIC

Med. Univ. Wien0 sites150 target enrollmentStarted: April 19, 2011Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
150

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •Diagnosis of glioblastoma IV, non small cell lung carcinoma IV and metastasized sarcoma within the last 8 weeks.
  • •Patients aged over 18 years
  • •signed informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years)
  • •F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • •intake of homeopathic remedies except the prescribed ones;
  • •refusal of intake of the prescribed homeopathic remedies

Investigators

Sponsor
Med. Univ. Wien

Similar Trials